Robert T Fritz, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 75 Herrick St, Suite 113, Beverly, MA 01915 Phone: 978-921-0944 Fax: 978-927-5844 |
John R Dainton, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 75 Herrick St, Suite 216, Beverly, MA 01915 Phone: 978-927-5611 Fax: 978-927-5404 |
News Archive
During last night's face off, Vice President Joe Biden and GOP vice presidential hopeful Paul Ryan offered different plans, visions and, sometimes, even numbers for Medicare's future.
Results from the Phase 2 RESONATE-17 (PCYC-1117) study show IMBRUVICA (ibrutinib) was associated with an 82.6 percent investigator-assessed overall response rate (ORR; the primary endpoint) and a 79 percent progression-free survival (PFS) rate at 12 months in people living with relapsed/refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have a genetic mutation known as deletion 17p (del 17p).
The coronavirus responsible for Middle East Respiratory Syndrome (MERS) is prevalent in camels throughout Saudi Arabia and has been around for at least 20 years, according to a study to be published on February 25 in mBio-, the online open-access journal of the American Society for Microbiology.
Glioma, one of the most deadly and common types of brain tumor, is often associated with seizures, but the origins of these seizures and effective treatments for them have been elusive. Now a team funded by the National Institutes of Health has found that human gliomas implanted in mice release excess levels of the brain chemical glutamate, overstimulating neurons near the tumor and triggering seizures.
› Verified 6 days ago